We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-3.87%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.25B
AUM Growth
-$80.1M
Cap. Flow
-$8.57M
Cap. Flow %
-0.69%
Top 10 Hldgs %
27.89%
Holding
407
New
48
Increased
129
Reduced
156
Closed
31

Sector Composition

1 Healthcare 36.63%
2 Consumer Staples 24.2%
3 Technology 9.24%
4 Communication Services 8.31%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
1
AbbVie
ABBV
$449B
$36.6M 2.94%
245,651
-32,141
-12% -$4.72M
MRK icon
2
Merck
MRK
$315B
$36.6M 2.94%
355,347
+1,199
+0.3% +$129K
JNJ icon
3
Johnson & Johnson
JNJ
$602B
$36.3M 2.92%
233,314
+11,521
+5% +$1.9M
GIS icon
4
General Mills
GIS
$20.7B
$36M 2.89%
562,716
+67,750
+14% +$4.79M
K
5
DELISTED
Kellanova
K
$35.6M 2.86%
637,530
+31,448
+5% +$1.87M
CLX icon
6
Clorox
CLX
$11.9B
$34.8M 2.79%
265,390
+27,415
+12% +$4.17M
BMY icon
7
Bristol-Myers Squibb
BMY
$124B
$33.5M 2.68%
576,350
+6,437
+1% +$394K
NBIX icon
8
Neurocrine Biosciences
NBIX
$17.2B
$33.4M 2.68%
297,184
-14,531
-5% -$1.53M
UTHR icon
9
United Therapeutics
UTHR
$22.5B
$32.8M 2.64%
145,420
-3,073
-2% -$708K
NEM icon
10
Newmont
NEM
$97B
$31.8M 2.55%
861,548
+54,559
+7% +$2.22M
PFE icon
11
Pfizer
PFE
$143B
$31.5M 2.53%
949,845
-82,818
-8% -$2.93M
LLY icon
12
Eli Lilly
LLY
$1.04T
$31.4M 2.52%
58,541
+18,294
+45% +$9.43M
HUM icon
13
Humana
HUM
$46.4B
$30.1M 2.41%
61,814
+1,248
+2% +$586K
KR icon
14
Kroger
KR
$35.9B
$29.2M 2.35%
653,603
+22,212
+4% +$1.05M
CHD icon
15
Church & Dwight Co
CHD
$23.5B
$28.9M 2.32%
315,134
-51,860
-14% -$4.97M
SJM icon
16
J.M. Smucker
SJM
$12.2B
$28.3M 2.27%
230,357
+20,099
+10% +$2.86M
CPB icon
17
Campbell Soup
CPB
$6.75B
$26.2M 2.11%
638,539
+1,960
+0.3% +$85.7K
MCK icon
18
McKesson
MCK
$98.5B
$26M 2.08%
59,679
+10,092
+20% +$4.25M
TTWO icon
19
Take-Two Interactive
TTWO
$44.5B
$25.4M 2.04%
180,712
-40,743
-18% -$5.86M
HRL icon
20
Hormel Foods
HRL
$14.1B
$23.3M 1.87%
613,276
-10,094
-2% -$398K
T icon
21
AT&T
T
$153B
$22.5M 1.81%
1,500,182
+813,488
+118% +$11.9M
HSY icon
22
Hershey
HSY
$35.4B
$22.1M 1.78%
110,573
+23,415
+27% +$5.24M
SLB icon
23
SLB Ltd
SLB
$70.4B
$22M 1.77%
378,199
-106,355
-22% -$6.17M
FSLR icon
24
First Solar
FSLR
$22.8B
$20.6M 1.65%
127,550
+8,191
+7% +$1.53M
CBOE icon
25
Cboe Global Markets
CBOE
$29.1B
$19.6M 1.57%
125,370
-15,394
-11% -$2.26M

Similar funds

TOBAM's Q3 2023 Portfolio in Review

As of Q3 2023, TOBAM held 407 positions worth $1.25B, down 6% from $1.33B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TOBAM's Q3 2023 filing shows 48 new, 129 increased, 156 reduced and 31 closed positions. Its largest new stake was SiriusXM: 209,530 shares worth $9.47M. The largest sale was Assurant, an estimated $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Technology.

  • TOBAM's largest Q3 2023 buy was SiriusXM: 209,530 shares worth $9.47M.
  • TOBAM added most to Arista Networks in Q3 2023, an estimated $15.8M increase.
  • TOBAM's biggest Q3 2023 reduction was Gen Digital, cutting an estimated $15.3M.
  • TOBAM fully exited Assurant in Q3 2023, selling an estimated $21.2M.
  • TOBAM's ten largest holdings make up 28% of its $1.25B portfolio in Q3 2023.
  • TOBAM opened 48 new positions and closed 31 in Q3 2023.
  • TOBAM's portfolio value fell 6% quarter-over-quarter to $1.25B.

Based on TOBAM's 13F filing for Q3 2023, filed 31 Oct 2023.